2023 saw a number of ground-breaking medical advances, such as proof of the cardiovascular advantages of anti-obesity GLP-1 medications, FDA approval of the RSV vaccine “Arexvy,” and approval of lecanemab for the treatment of Alzheimer’s. Notably, the WHO’s designation of sucralose as “genotoxic” raised concerns. Although the study used human blood cells and required extremely […]
English (US) ·